- Home
- GGR vs WHWK Comparison
GGR vs WHWK Comparison
Compare GGR & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGR
- WHWK
- Stock Information
- Founded
- GGR 2011
- WHWK 2007
- Country
- GGR Taiwan
- WHWK United States
- Employees
- GGR N/A
- WHWK N/A
- Industry
- GGR Auto Manufacturing
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- GGR Consumer Discretionary
- WHWK Health Care
- Exchange
- GGR Nasdaq
- WHWK Nasdaq
- Market Cap
- GGR 80.6M
- WHWK 87.6M
- IPO Year
- GGR N/A
- WHWK N/A
- Fundamental
- Price
- GGR $0.38
- WHWK $1.92
- Analyst Decision
- GGR Hold
- WHWK
- Analyst Count
- GGR 2
- WHWK 0
- Target Price
- GGR $0.50
- WHWK N/A
- AVG Volume (30 Days)
- GGR 477.4K
- WHWK 149.8K
- Earning Date
- GGR 08-14-2025
- WHWK 08-15-2025
- Dividend Yield
- GGR N/A
- WHWK N/A
- EPS Growth
- GGR N/A
- WHWK N/A
- EPS
- GGR N/A
- WHWK 0.91
- Revenue
- GGR $304,551,000.00
- WHWK $27,775,000.00
- Revenue This Year
- GGR N/A
- WHWK $49.83
- Revenue Next Year
- GGR $5.00
- WHWK N/A
- P/E Ratio
- GGR N/A
- WHWK $2.09
- Revenue Growth
- GGR N/A
- WHWK 16.51
- 52 Week Low
- GGR $0.19
- WHWK $1.21
- 52 Week High
- GGR $1.65
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- GGR 80.44
- WHWK N/A
- Support Level
- GGR $0.24
- WHWK N/A
- Resistance Level
- GGR $0.42
- WHWK N/A
- Average True Range (ATR)
- GGR 0.02
- WHWK 0.00
- MACD
- GGR 0.02
- WHWK 0.00
- Stochastic Oscillator
- GGR 85.55
- WHWK 0.00
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.